| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/04/2004 | US20040044073 Composition and process for treating acne |
| 03/04/2004 | US20040044072 Substituted hydroxyethylamines |
| 03/04/2004 | US20040044070 Cardiovascular disorders; antiarrhythmia agents |
| 03/04/2004 | US20040044069 Anti-virus compounds |
| 03/04/2004 | US20040044067 Anticholesterol agents; dietetics; plant extract |
| 03/04/2004 | US20040044064 Administering melatonin, or antagonist thereof; uniform blood concentration |
| 03/04/2004 | US20040044063 SMA therapy and cell based assay for identifying therapies |
| 03/04/2004 | US20040044061 Analgesics; side effect reduction |
| 03/04/2004 | US20040044058 Novel 4'-demethyl-4'-o-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same |
| 03/04/2004 | US20040044057 5- substituted tetralones as inhibitors of ras farnesyl trransferase |
| 03/04/2004 | US20040044055 N-alkoxlyalkyl-substituted benzimidazoles and the use thereof as an agent against parastic protozoans |
| 03/04/2004 | US20040044052 N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| 03/04/2004 | US20040044051 Cannabinoid receptor agonists |
| 03/04/2004 | US20040044050 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 03/04/2004 | US20040044049 Compounds for inhibiting insulin secretion and methods related thereto |
| 03/04/2004 | US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/04/2004 | US20040044046 Mixture of nicotinamide |
| 03/04/2004 | US20040044045 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 03/04/2004 | US20040044044 Thiazolyl urea compounds and methods of uses |
| 03/04/2004 | US20040044043 Hyperglycemic agents; antilipemic agents |
| 03/04/2004 | US20040044042 Process for preparing heterocyclo-alkylsulfonyl pyrazole derivatives |
| 03/04/2004 | US20040044039 Antiemetic compositions of optically pure (+) norcisapride |
| 03/04/2004 | US20040044038 Polymorphic form XVI of fexofenadine hydrochloride |
| 03/04/2004 | US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders |
| 03/04/2004 | US20040044034 Tyrosine kinase inhibitor; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040044032 Using an (imidazol-5-yl-)methyl-2-quinolinone compound |
| 03/04/2004 | US20040044031 Controlling appetite; dietetics; sleep disorders |
| 03/04/2004 | US20040044030 Cardiovascular disorders; antiarrhythmia agents |
| 03/04/2004 | US20040044028 Synergistic mixtures; cardiovascular disorders, anticancer agents |
| 03/04/2004 | US20040044027 Induce immunology response; central nervous system disorders;sleep disorders; gastrointestinal disorders |
| 03/04/2004 | US20040044026 3-Substituted quinuclidines and their use as nicotinic agonists |
| 03/04/2004 | US20040044023 Mixture of cholinesterase inhibitor and another enzyme inhibitor |
| 03/04/2004 | US20040044022 Agent for treating neurodegenerative disorders |
| 03/04/2004 | US20040044021 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 03/04/2004 | US20040044020 Respiratory system disorders; antiinflammatory agents |
| 03/04/2004 | US20040044019 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
| 03/04/2004 | US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 03/04/2004 | US20040044016 Antiviral agents |
| 03/04/2004 | US20040044015 Quinazoline derivatives |
| 03/04/2004 | US20040044013 Antiarthritic agents; side effect reduction |
| 03/04/2004 | US20040044011 2-Aminoalkyl-thieno[2,3-d]pyrimidines |
| 03/04/2004 | US20040044010 Central nervous system disorders; Alzheimer's disease; Parkinson's disease |
| 03/04/2004 | US20040044009 Drug abuse; cental nervous system disorders; cognition activators |
| 03/04/2004 | US20040044008 Dietetics; antilipemic agents; non-insulin dependent diabetes; cardiovascular disorders |
| 03/04/2004 | US20040044007 Pyschological and central nervous system diosrders; neurolptics; side effect reduction |
| 03/04/2004 | US20040044006 Administering gemifloxacin against antibiotic resistant bacteria |
| 03/04/2004 | US20040044005 Nicotine addiction treatment |
| 03/04/2004 | US20040044004 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 03/04/2004 | US20040044003 Therapeutic agents useful for treating pain |
| 03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040044001 Use of II-1 inhibitors for treating II-1 mediated diseases |
| 03/04/2004 | US20040043999 Phthalazine derivatives as phosphodiesterase 4-inhibitors |
| 03/04/2004 | US20040043998 Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts |
| 03/04/2004 | US20040043996 Controlled release formulation of lamotrigine |
| 03/04/2004 | US20040043993 Premenstrual tension; anticancer agents; osteoporosis; hormone replacement therapy |
| 03/04/2004 | US20040043992 Prevention vascular occlusion |
| 03/04/2004 | US20040043990 Analgesics; devazepide |
| 03/04/2004 | US20040043989 Therapy for drug resistant bacteria; topoisomerase inhibitor |
| 03/04/2004 | US20040043981 Pharmaceutical composistions |
| 03/04/2004 | US20040043980 Bactericides; storage stability |
| 03/04/2004 | US20040043978 Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors |
| 03/04/2004 | US20040043977 Alzheimer's disease |
| 03/04/2004 | US20040043976 16Alpha-methyl or ethyl substituted estrogens |
| 03/04/2004 | US20040043975 Skin disorders; mixture of diclofenas and enzyme inhibitor |
| 03/04/2004 | US20040043973 Pharmaceutical compositions and treatment methods |
| 03/04/2004 | US20040043972 Autoimmune disease; antidiabetic agents |
| 03/04/2004 | US20040043971 Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
| 03/04/2004 | US20040043970 Method for reducing psa levels |
| 03/04/2004 | US20040043969 Tubulin binding agents and corresponding prodrug constructs |
| 03/04/2004 | US20040043968 Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treatment of urinary incontinence |
| 03/04/2004 | US20040043966 Using 1-hydroxy-2-(imidazolo(1,2-a)pyridin-3-yl)ethanediphosphonic acid; bone disorders |
| 03/04/2004 | US20040043963 Complex of chitosan, conjugated linoleic acid, vitamin a and cyclodextrin |
| 03/04/2004 | US20040043962 Method for enhancing the effectiveness of cancer therapies |
| 03/04/2004 | US20040043961 Transforming growth factor; antiwrinkle agent; skin disorders; using fucoidan |
| 03/04/2004 | US20040043960 Partial and full agonists of A1 adenosine receptors |
| 03/04/2004 | US20040043959 Combination therapies for treating methylthioadenosine phosphorylase deficient cells |
| 03/04/2004 | US20040043947 Methods of treating wounds or ulcers of the foot, ankle or lower extremity of the leg |
| 03/04/2004 | US20040043946 Storage stable mixture containing benzoyl peroxide and clindamycin |
| 03/04/2004 | US20040043945 Crystal forms of azithromycin |
| 03/04/2004 | US20040043944 Form of azithromycin selected from the group consisting of forms D, E, substantially pure F, G, J, M substantially in the absence of azithromycin dihydrate, N, O, P, Q, and R; NMR spectrun analysis; bactericides; antiprotozoa agents; infections of mammals, birtds, and fish; drug resistance |
| 03/04/2004 | US20040043943 Method for the management of incontinence |
| 03/04/2004 | US20040043941 Antiinflamamtory agents; autoimmune disease; anticancer agents |
| 03/04/2004 | US20040043938 Combination therapy for estrogen-dependent disorders |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043920 Chelate compound of metal and dithiocarbamate; therapy, diagnosis |
| 03/04/2004 | US20040043919 Method for the treatment of neurological and neuropsychological disorders |
| 03/04/2004 | US20040043918 Containing phosphatides; killing cancer, tumor cells |
| 03/04/2004 | US20040043454 Growth arrest homeobox gene |
| 03/04/2004 | US20040043442 Using glycine betaine to as a hypotensive agent in treating hypertension |
| 03/04/2004 | US20040043411 DSP-11 dual-specificity phosphatase |
| 03/04/2004 | US20040043410 Methods for testing for and inhibiting the development of Huntington's disease |
| 03/04/2004 | US20040043378 Methods of identifying modulators of bromodomains |
| 03/04/2004 | US20040043171 Transdermal drug delivery |
| 03/04/2004 | US20040043087 Activation of mask cells; synergistic mixture of anticancer drug |
| 03/04/2004 | US20040043086 Herbal based composition for treating acute and chronic myeloid leukemia |
| 03/04/2004 | US20040043083 Anticancer composition comprising sesquiterpenes isolated from resina ferulae |
| 03/04/2004 | US20040043082 Wound healing agent for eyes; dissolving glycoproteins |
| 03/04/2004 | US20040043077 Production of microspheres |
| 03/04/2004 | US20040043075 Topical applying; vision defects |
| 03/04/2004 | US20040043074 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |